KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Inventory (2021 - 2025)

Novavax (NVAX) has 5 years of Change in Inventory data on record, last reported at -$2.1 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 1236.51% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached $3.2 million, up 125.09%, while the annual FY2025 figure was $3.2 million, 125.09% up from the prior year.
  • Change in Inventory reached -$2.1 million in Q4 2025 per NVAX's latest filing, down from $3.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $304.2 million in Q2 2022 and bottomed at -$16.8 million in Q1 2024.
  • Average Change in Inventory over 5 years is $32.4 million, with a median of $4.0 million recorded in 2025.
  • Peak YoY movement for Change in Inventory: skyrocketed 478.62% in 2022, then plummeted 1236.51% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $8.9 million in 2021, then surged by 478.62% to $51.3 million in 2022, then tumbled by 115.75% to -$8.1 million in 2023, then surged by 102.34% to $189000.0 in 2024, then crashed by 1236.51% to -$2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$2.1 million in Q4 2025, $3.8 million in Q3 2025, and $4.0 million in Q2 2025.